4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-25-000101
Chief Financial Officer sold 4,304 shares at $12.01 ($51,695)
- Chief Financial Officer acquired 11,494 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
van Houte Hans · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-30 | Exercise or conversion : show line 1 in the form | +2,886 | 36,610 | D | ||
| 2025-07-30 | Exercise or conversion : show line 2 in the form | +2,000 | 38,610 | D | ||
| 2025-07-30 | Exercise or conversion : show line 3 in the form | +3,750 | 42,360 | D | ||
| 2025-07-30 | Exercise or conversion : show line 4 in the form | +2,858 | 45,218 | D | ||
| 2025-07-30 | Sale : show line 5 in the form | −4,304 | $12.01 | $51,695 | 40,914 | D |
| Open-market sales · 4,304 sh · avg $12.01 · $51,695 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-30 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −2,886 | 5,773 | D |
| 2025-07-30 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −2,000 | 6,000 | D |
| 2025-07-30 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −3,750 | 26,250 | D |
| 2025-07-30 | Exercise or conversion : show line 9 in the form Restricted Stock Units | −2,858 | 31,442 | D |
Loading xslF345X05/wk-form4_1753915745.xml…